COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 14.29
(0.0%)
CNY 14.29
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2 Billion CNY | -96.12% |
| 2022 | 1.59 Billion CNY | 112.29% |
| 2021 | 2.54 Billion CNY | 76.68% |
| 2020 | 626.7 Million CNY | -67.93% |
| 2019 | 2.04 Billion CNY | 6157.06% |
| 2018 | 1.1 Billion CNY | 149.84% |
| 2017 | -121.65 Million CNY | -158.56% |
| 2016 | 126.91 Million CNY | 269.63% |
| 2015 | -100.66 Million CNY | -226.45% |
| 2014 | 63.85 Million CNY | -48.71% |
| 2013 | 121 Million CNY | -32.88% |
| 2012 | 184.56 Million CNY | -0.66% |
| 2011 | 181.2 Million CNY | 13.49% |
| 2010 | 174.41 Million CNY | -17.43% |
| 2009 | 158.78 Million CNY | -0.31% |
| 2008 | 151.24 Million CNY | 37.74% |
| 2007 | 134.94 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -969.12 Million CNY | -263.63% |
| 2024 Q1 | -896.59 Million CNY | -238.34% |
| 2024 Q3 | -322.77 Million CNY | 66.69% |
| 2023 FY | - CNY | -96.12% |
| 2023 Q3 | -41.85 Million CNY | -107.5% |
| 2023 Q4 | 87.45 Million CNY | 308.93% |
| 2023 Q2 | 557.88 Million CNY | 173.03% |
| 2023 Q1 | -763.91 Million CNY | -261.56% |
| 2022 Q4 | 472.82 Million CNY | -61.78% |
| 2022 Q3 | 1.23 Billion CNY | 404.16% |
| 2022 Q2 | -406.68 Million CNY | -126.84% |
| 2022 Q1 | 1.51 Billion CNY | 369.81% |
| 2022 FY | - CNY | 112.29% |
| 2021 FY | - CNY | 76.68% |
| 2021 Q4 | 322.45 Million CNY | -38.44% |
| 2021 Q2 | -405.67 Million CNY | -153.73% |
| 2021 Q1 | 754.96 Million CNY | 45.14% |
| 2021 Q3 | 523.84 Million CNY | 229.13% |
| 2020 FY | - CNY | -67.93% |
| 2020 Q3 | 431.66 Million CNY | 159.22% |
| 2020 Q2 | -728.95 Million CNY | -251.97% |
| 2020 Q1 | 479.66 Million CNY | -47.07% |
| 2020 Q4 | 520.16 Million CNY | 20.5% |
| 2019 Q3 | 196.76 Million CNY | -72.83% |
| 2019 FY | - CNY | 6157.06% |
| 2019 Q1 | 352.77 Million CNY | 2242.91% |
| 2019 Q2 | 724.14 Million CNY | 105.27% |
| 2019 Q4 | 906.22 Million CNY | 360.56% |
| 2018 FY | - CNY | 149.84% |
| 2018 Q4 | -16.46 Million CNY | -2724.6% |
| 2018 Q3 | -582.82 Thousand CNY | 13.23% |
| 2018 Q2 | -671.71 Thousand CNY | 96.48% |
| 2018 Q1 | -19.1 Million CNY | 70.14% |
| 2017 Q4 | -63.96 Million CNY | -80.78% |
| 2017 FY | - CNY | -158.56% |
| 2017 Q1 | -27.7 Million CNY | -121.04% |
| 2017 Q2 | -36.22 Million CNY | -30.74% |
| 2017 Q3 | -35.38 Million CNY | 2.31% |
| 2016 Q2 | -3.45 Million CNY | 85.8% |
| 2016 FY | - CNY | 269.63% |
| 2016 Q4 | 131.68 Million CNY | 597.85% |
| 2016 Q3 | -26.45 Million CNY | -665.71% |
| 2016 Q1 | -24.32 Million CNY | 74.95% |
| 2015 FY | - CNY | -226.45% |
| 2015 Q1 | -6.77 Million CNY | -606.84% |
| 2015 Q2 | -5.27 Million CNY | 22.22% |
| 2015 Q3 | -49.18 Million CNY | -832.72% |
| 2015 Q4 | -97.12 Million CNY | -97.45% |
| 2014 Q2 | 4.36 Million CNY | 258.8% |
| 2014 FY | - CNY | -48.71% |
| 2014 Q3 | -6.51 Million CNY | -249.42% |
| 2014 Q1 | -2.74 Million CNY | -103.7% |
| 2014 Q4 | -959.16 Thousand CNY | 85.29% |
| 2013 Q2 | 3.3 Million CNY | 112.59% |
| 2013 Q1 | -26.23 Million CNY | -115.54% |
| 2013 FY | - CNY | -32.88% |
| 2013 Q4 | 74.26 Million CNY | 2812.98% |
| 2013 Q3 | -2.73 Million CNY | -182.84% |
| 2012 Q2 | -30.29 Million CNY | -1216.99% |
| 2012 FY | - CNY | -0.66% |
| 2012 Q4 | 168.83 Million CNY | 655.17% |
| 2012 Q3 | -30.41 Million CNY | -0.39% |
| 2012 Q1 | -2.3 Million CNY | -102.48% |
| 2011 Q2 | 52.8 Million CNY | 346.0% |
| 2011 Q1 | 11.83 Million CNY | -84.48% |
| 2011 FY | - CNY | 13.49% |
| 2011 Q3 | -7.1 Million CNY | -113.46% |
| 2011 Q4 | 92.61 Million CNY | 1402.87% |
| 2010 FY | - CNY | -17.43% |
| 2010 Q1 | 31.55 Million CNY | -63.82% |
| 2010 Q2 | -2.5 Million CNY | -107.93% |
| 2010 Q3 | 5.95 Million CNY | 337.89% |
| 2010 Q4 | 76.28 Million CNY | 1181.05% |
| 2009 Q3 | 31.67 Million CNY | 301.68% |
| 2009 Q1 | 21.56 Million CNY | 0.0% |
| 2009 Q2 | 7.88 Million CNY | -63.43% |
| 2009 FY | - CNY | -0.31% |
| 2009 Q4 | 87.21 Million CNY | 175.34% |
| 2008 FY | - CNY | 37.74% |
| 2007 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 1.21 Billion CNY | -64.709% |